Psychiatric disorders in Huntington's disease: a 2-year follow-up study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Psychosomatics

• Publication date

  2012-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psym.2011.12.010PMID 22458993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychiatric history and subthreshold symptoms as predictors of the occurrence of depressive or anxiety disorder within 2 years.

  2011cited by this paper
• Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

  2011cited by this paper
• Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY

  2011cited by this paper
• Challenges assessing clinical endpoints in early Huntington disease

  2010cited by this paper
• Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY.

  2010cited by this paper
• Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.

  2008cited by this paper
• Effect of CAG repeat length on psychiatric disorders in Huntington's disease.

  2008cited by this paper
• The World Health Organization composite international diagnostic interview.

  2008cited by this paper
• The assessment of depression in Parkinson’s disease

  2008cited by this paper
• Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives.

  2008influential reference
• Psychopathology in verified Huntington's disease gene carriers.

  2007cited by this paper
• Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

  2007influential reference
• A prospective study in one year cumulative incidence of depression after ischemic stroke and Parkinson's disease: a preliminary study.

  2007cited by this paper
• Preparing for preventive clinical trials: the Predict-HD study.

  2006cited by this paper
• Depression and stages of Huntington's disease.

  2005cited by this paper
• Huntington's disease: present treatments and future therapeutic modalities

  2004cited by this paper
• Behavioural abnormalities contribute to functional decline in Huntington’s disease

  2003cited by this paper
• 한국어판 Composite International Diagnostic Interview의 타당도

  2003cited by this paper
• Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects

  2002cited by this paper
• Longitudinal personality changes among presymptomatic Huntington disease gene carriers.

  2002cited by this paper
• Provisional diagnostic criteria for depression of Alzheimer disease.

  2002cited by this paper
• Studies of Interference in Serial Verbal Reactions

  2001cited by this paper
• Progression of symptoms in the early and middle stages of Huntington disease.

  2001cited by this paper
• Treatment of the Psychiatric Manifestations of Huntington's Disease: A Review of the Literature

  1998cited by this paper
• The psychometric properties of the Composite International Diagnostic Interview

  1998cited by this paper
• Unified Huntington's disease rating scale: reliability and consistency

  1996cited by this paper
• Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.

  1996cited by this paper
• Unified Huntington's disease rating scale: Reliability and consistency

  1996cited by this paper
• Cognitive assessment for clinicians

  1994cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• An estimate of the incidence of depression in idiopathic Parkinson's disease.

  1992cited by this paper
• J Neuropsychiatry Clin Neurosci

  1992cited by this paper
• Huntington's disease

  1991cited by this paper
• Huntington's disease

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Depression in Premanifest Huntington's Disease: Aberrant Effective Connectivity of Striatum and Default Mode Network

  2025cites this paper
• Coping with Huntington’s Disease in Patients and At-Risk Individuals

  2024cites this paper
• Depression in Premanifest Huntingtons Disease: Effective Connectivity of Striatum and Default Mode Network

  2024cites this paper
• Gene-dosage- and sex-dependent differences in the prodromal-Like phase of the F344tgHD rat model for Huntington disease

  2024cites this paper
• Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review

  2023cites this paper
• Nursing Approaches and Perceived Quality of Life in Advanced Stage Huntington’s Disease Patients

  2022cites this paper
• Huntington’s Chorea—a Rare Neurodegenerative Autosomal Dominant Disease: Insight into Molecular Genetics, Prognosis and Diagnosis

  2021cites this paper
• Calcium Dysregulation and Compensation in Cortical Pyramidal Neurons of the R6/2 Mouse Model of Huntington's Disease.

  2021cites this paper
• Linking Huntington disease, brain-derived neurotrophic factor, and depressive-like behaviors

  2021cites this paper
• Understanding domains that influence perceived stigma in individuals with Huntington disease.

  2020cites this paper
• Gene Expression Profiling in Huntington’s Disease: Does Comorbidity with Depressive Symptoms Matter?

  2020cites this paper
• Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD)

  2020cites this paper
• Why Woody got the blues: The neurobiology of depression in Huntington's disease.

  2020cites this paper
• Seeking for potential pathogenic genes of major depressive disorder in the Gene Expression Omnibus database

  2019cites this paper
• Pathology, Prevention and Therapeutics of Neurodegenerative Disease

  2019cites this paper
• Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease

  2019cites this paper
• Huntington’s disease and NMDA receptors; a new arena for therapeutic development

  2018cites this paper
• Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease

  2018cites this paper
• Pathophysiological Mechanisms of Huntington’s Disease

  2018cites this paper
• Neuropsychiatric Burden in Huntington’s Disease

  2017influential citation
• Systematic Review of Prevalence of depression in Huntington ’ s Disease

  2017cites this paper
• Risk factors for the onset and progression of Huntington disease

  2017influential citation
• Cognitive and behavioral changes in Huntington disease before diagnosis.

  2017cites this paper
• Huntington's Disease and Other Choreas

  2017cites this paper
• The role of serotonergic dysfunction in the etiology of affective disorder in a Huntington’s disease translational mouse model

  2017cites this paper
• Spanish Validation of the Problem Behaviors Assessment-Short (PBA-s) for Huntington's Disease.

  2017cites this paper
• Neurochemical correlation between major depressive disorder and neurodegenerative diseases.

  2016cites this paper
• Alteraciones Neurofisiológicas producidas por la Enfermedad de Huntington sobre la Calidad de Vida

  2016cites this paper
• Anxiety in Huntington's Disease.

  2015cites this paper
• Antidepressants for neuroprotection in Huntington's disease: A review.

  2015cites this paper
• The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.

  2014cites this paper
• Psychosis with Huntington's disease: role of antipsychotic medications

  2014cites this paper
• Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms

  2014cites this paper
• Role of cerebral cortex in the neuropathology of Huntington's disease

  2013cites this paper
• Selective executive dysfunction but intact risky decision‐making in early Huntington's disease

  2013cites this paper
• EEG Correlates of Emotional Experience in Huntington's Disease

  2013cites this paper
• Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse

  2012cites this paper